BakerHostetler
Alumni Login
| Subscribe | Print
Open search/close search button Open menu/close menu button
Services
Professionals
About Us
Offices
News/Resources
Diversity
Careers
Alumni

Ronald C. Kern Jr., Ph.D.

Associate

Philadelphia
T +1.215.564.1669
F +1.215.568.3439
rkern@bakerlaw.com
Download Vcard

Overview

Ron Kern uses his extensive scientific research experience in biochemistry and molecular biology to assist a wide range of clients, including Fortune 500 companies, start-up companies and universities, to develop and implement patent strategies in the life science arena. Ron specializes in the areas of protein therapeutics, diagnostics, medical devices, and laboratory instruments and techniques. His practice includes drafting and prosecuting U.S. and foreign patents; advising clients of the risks associated with practicing a technology of interest; advising clients of the patentability of a technology of interest; drafting clearance opinions; drafting ex parte reexamination petitions and inter partes review petitions; and counseling clients on growing and maintaining patent portfolios.

Select Experience

  • Assisted a large, multinational pharmaceutical company in a multi-million dollar technology licensing deal.
  • Provided clearance opinion to a large, multinational pharmaceutical company relating to the launch of a new commercial product.
  • Performs freedom-to-operate and patentability assessments for a large, multinational pharmaceutical company.
More »

Experience

  • Assisted a large, multinational pharmaceutical company in a multi-million dollar technology licensing deal.
  • Provided clearance opinion to a large, multinational pharmaceutical company relating to the launch of a new commercial product.
  • Performs freedom-to-operate and patentability assessments for a large, multinational pharmaceutical company.
  • Drafted ex parte reexamination petitions for a Fortune 500, global science company in advance of the launch of a new commercial product.
  • Successfully appealed a patent examiner’s rejection of a multinational medical device company’s pending patent claims to the Patent Trial and Appeal Board.
  • Drafted more than 90 patent applications and prosecuted hundreds of U.S. and foreign patent applications.
  • Assisted a large U.S. corporation in obtaining a favorable settlement agreement through the use of inter partes review proceedings and motions for summary judgment.

Recognitions and Memberships

Memberships

  • Philadelphia Intellectual Property Law Association
    • Board of Governors (2015 to 2017)
    • Hospitality Committee (2013 to 2015)

Blog Posts

Community

  • Living Beyond Breast Cancer: Board of Directors (2015 to 2017)

Services

Industries

Admissions

  • U.S. District Court, Eastern District of Pennsylvania
  • U.S. Patent and Trademark Office, Registration No. 71,482
  • Pennsylvania
  • New Jersey

Education

  • J.D., Drexel University Thomas R. Kline School of Law, 2012, cum laude, with honors in Intellectual Property
  • Ph.D., Molecular Pharmacology and Structural Biology, Thomas Jefferson University, 2009
  • B.S., Biochemistry and Molecular Biology, Pennsylvania State University, 2002, with honors

Blog

In The Blogs

Previous Next
IP Intelligence: Insight on Intellectual Property
The Federal Circuit Opens the Door Wider for the Subject Matter Eligibility of Methods of Treatment, Compositions and Methods of Manufacturing
By Ronald C. Kern Jr., Ph.D.
March 18, 2019
“We live in a natural world, and all inventions are constrained by the laws of nature . . . we must be careful not to overly abstract claims when performing the Alice analysis.”[1] These are the promising words from the Federal Circuit in...
Read More ->
IP Intelligence: Insight on Intellectual Property
Federal Circuit holds that claims directed to diagnosing neurotransmission or developmental disorders are invalid for failing to recite patent eligible subject matter
By Ronald C. Kern Jr., Ph.D.
February 11, 2019
In Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC,[1] the Federal Circuit affirmed the district court’s ruling that claims covering methods for diagnosing neurological disorders by detecting autoantibodies are directed to a...
Read More ->

Services

Find Professionals

Offices

About Us

Careers

Firm Diversity

LinkedIn Twitter Facebook Instagram Youtube RSS
Subscribe »
© 2021 Baker & Hostetler LLP